Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Toripalimab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07307456
What this trial is testing

Toripalimab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration

Who this might be right for
Bladder Cancer
Changhai Hospital 31
Large-scale testing (Phase 3)Looking for participantsNCT07693959
What this trial is testing

Neoadjuvant RC48 Plus Gemcitabine in HER2-Expressing MIBC

Who this might be right for
MIBC
Zhiquan Hu 170
Testing effectiveness (Phase 2)Looking for participantsNCT06038396
What this trial is testing

RC118 Plus Toripalimab / RC148 in Patients with Locally Advanced Unresectable or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumor
RemeGen Co., Ltd. 48
Testing effectiveness (Phase 2)Study completedNCT04005170
What this trial is testing

Combination of Toripalimab and Chemoradiotherapy in Esophageal Cancer

Who this might be right for
Unresectable Esophageal Cancer
Mian XI 42
Testing effectiveness (Phase 2)Looking for participantsNCT06611813
What this trial is testing

Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01)

Who this might be right for
HR+/HER2- Breast Cancer
First Affiliated Hospital of Zhejiang University 30
Testing effectiveness (Phase 2)Looking for participantsNCT05800340
What this trial is testing

Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC

Who this might be right for
Non-Small Cell Lung CancerRET Driver MutationBRAF V600 Mutation+3 more
Guangdong Provincial People's Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06020755
What this trial is testing

Toripalimab Plus Actinomycin-D As Fist-Line Treatment for GTN with FIGO Score 7

Who this might be right for
Gestational Trophoblastic Neoplasia
Peking Union Medical College Hospital 17
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07272291
What this trial is testing

A Phase II Study of Toripalimab Plus Chemotherapy and Low-Dose Radiotherapy for Neoadjuvant Therapy-Refractory Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Tianjin Medical University Cancer Institute and Hospital 48
Testing effectiveness (Phase 2)UnknownNCT05055583
What this trial is testing

Toripalimab in Combination With Platinum-based Chemotherapy for Mutation-negative Stage IV Oligometastatic NSCLC

Who this might be right for
NSCLC Stage IVOligometastasis
Tang-Du Hospital 30
Testing effectiveness (Phase 2)UnknownNCT04368273
What this trial is testing

Pd-1 Antibody Combined CCRT for Local Advanced Cervical Cancer.

Who this might be right for
Cervical Cancer
Peking University Third Hospital 30
Testing effectiveness (Phase 2)UnknownNCT05760053
What this trial is testing

Toripalimab Plus Etoposide and Platinum-based Chemotherapy for Genitourinary Small Cell Carcinoma

Who this might be right for
ToripalimabFirst-line Treatment
Sun Yat-sen University 33
Early research (Phase 1)Looking for participantsNCT07625423
What this trial is testing

Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic Head and Neck Tumors

Who this might be right for
Head & Neck CancerNasopharyngeal Cancinoma (NPC)
West China Hospital 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07685535
What this trial is testing

HAIC + DEB-TACE + Toripalimab + Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Liver Cancer
Shanghai Zhongshan Hospital 29
Testing effectiveness (Phase 2)UnknownNCT05274438
What this trial is testing

Imatinib and Toripalimab in Patients With Locally Advanced/Metastatic Melanoma Harbored With CKIT Mut

Who this might be right for
Advanced Melanoma
Peking University Cancer Hospital & Institute 37
Large-scale testing (Phase 3)Not Yet RecruitingNCT07371897
What this trial is testing

Toripalimab ± Chemo as Neoadjuvant Therapy in LA-HNSCC: A Phase III Trial

Who this might be right for
Head and Neck Squamous Cell Carcinoma HNSCC
Sun Yat-sen University 154
Large-scale testing (Phase 3)Study completedNCT04085276
What this trial is testing

Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment

Who this might be right for
Triple-Negative Breast Cancer
Shanghai Junshi Bioscience Co., Ltd. 531
Testing effectiveness (Phase 2)UnknownNCT04613804
What this trial is testing

Toripalimab as Maintenance Therapy in Patients With Driver-gene Negative Advanced NSCLC After First-line Chemotherapy

Who this might be right for
NSCLC Stage IV
Fujian Cancer Hospital 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06679985
What this trial is testing

A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Coherus Oncology, Inc. 72
Early research (Phase 1)Not Yet RecruitingNCT06283134
What this trial is testing

A Clinical Study of BioTTT001 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
China Medical University, China 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808216
What this trial is testing

Toripalimab Combined With Intravesical Gemcitabine as Adjuvant Therapy for High-Risk Non-Muscle-Invasive Bladder Cancer After TURBT

Who this might be right for
Non Muscle Invasive Bladder Cancer
Tianjin First Central Hospital 54
Next Page